Clin Neurol Neurosurg
January 2011
Object: To explore the feasibility of using botulinum toxin type A (BTXA) to treat tinnitus due to stapedius myoclonus.
Method: A piece of gelfoam containing BTXA (25 U/ml) was placed, through a perforation in tympanic membrane, into the middle ear cavity of a patient suffering from tinnitus due to stapedius myoclonus.
Results: The tinnitus disappeared on the second day after the BTXA treatment.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
January 2005